Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-23

Clinical Trial Update: Bupivacaine Injection of Eye Muscles to Treat Strabismus [Phase 2, Phase 3]

View source ↗

Summary

Clinical trials are evaluating bupivacaine injections into eye muscles for treating strabismus across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)

Snippet

Sponsor: Smith-Kettlewell Eye Research Institute | Conditions: Strabismus, Esotropia | Phase 2, Phase 3 | Status: UNKNOWN